Cargando…
Clinical Evaluation of Patients with Genetically Confirmed Familial Hypercholesterolemia
Familial hypercholesterolemia (FH) is the most common genetic disorder associated with premature atherosclerotic cardiovascular (CV) disease (ASCVD). However, it still is severely underdiagnosed. Initiating lipid-lowering therapy (LLT) in FH patients early in life can substantially reduce their ASCV...
Autores principales: | Aparicio, Andrea, Villazón, Francisco, Suárez-Gutiérrez, Lorena, Gómez, Juan, Martínez-Faedo, Ceferino, Méndez-Torre, Edelmiro, Avanzas, Pablo, Álvarez-Velasco, Rut, Cuesta-Llavona, Elías, García-Lago, Claudia, Neuhalfen, David, Coto, Eliecer, Lorca, Rebeca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917940/ https://www.ncbi.nlm.nih.gov/pubmed/36769678 http://dx.doi.org/10.3390/jcm12031030 |
Ejemplares similares
-
Opportunistic Genetic Screening for Familial Hypercholesterolemia in Heart Transplant Patients
por: Salgado, María, et al.
Publicado: (2023) -
Familial Hypercholesterolemia in Premature Acute Coronary Syndrome. Insights from CholeSTEMI Registry
por: Lorca, Rebeca, et al.
Publicado: (2020) -
Chromosome Y Haplogroup R Was Associated with the Risk of Premature Myocardial Infarction with ST-Elevation: Data from the CholeSTEMI Registry
por: Lorca, Rebeca, et al.
Publicado: (2023) -
Mitochondrial Heteroplasmy as a Marker for Premature Coronary Artery Disease: Analysis of the Poly-C Tract of the Control Region Sequence
por: Lorca, Rebeca, et al.
Publicado: (2023) -
Clinical Implications and Gender Differences of KCNQ1 p.Gly168Arg Pathogenic Variant in Long QT Syndrome
por: Lorca, Rebeca, et al.
Publicado: (2020)